Peripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence
Diseases of the Respiratory System
What is the purpose of this trial?
The purpose of this study is to screen patients at risk for lung cancer, or lung cancer recurrence using a novel sequencing technique to detect fragments of mutated DNA in the peripheral blood.
- Trial withYale University School of Medicine
- Start Date09/02/2014
- End Date09/29/2024
- Last Updated07/15/2021
- Study HIC#1407014379